Current Validated Clinical and Patient Reported Disease Outcome Measures in Juvenile Idiopathic Arthritis

References

• Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138–2149. doi:10.1016/S0140-6736(11)60244-4
   PubMed Web of Science ®Google Scholar
• The OMERACT Handbook. In: Beaton D, Maxwell L,Grosskleg S, Shea B, Tugwell B, Eds. Updated April 2021. Available from: https://omeract.org/wp-content/uploads/2021/12/OMERACT-Handbook-Chapter-5_Final_June-2-2021_a.pdf. Accessed January 11, 2023.
   Google Scholar
• Wallace CA, Ravelli A, Huang B, Giannini EH. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol. 2006;33(4):789–795.
   PubMed Web of Science ®Google Scholar
• Wallace CA, Ruperto N. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290–2294.
   PubMed Web of Science ®Google Scholar
• Consolaro A, Ruperto N, Bazso A, et al. Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS). Pediatr Rheumatol. 2008;6(1):P115. doi:10.1186/1546-0096-6-S1-P115
   Google Scholar
• Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Care Res. 2009;61(5):658–666. doi:10.1002/art.24516
   Web of Science ®Google Scholar
• Trincianti C, Van Dijkhuizen EHP, Alongi A, et al. Definition and validation of the American college of rheumatology 2021 juvenile arthritis disease activity score cutoffs for disease activity states in juvenile idiopathic arthritis. Arthritis Rheumatol. 2021;73(11):1966–1975. doi:10.1002/art.41879
   PubMed Web of Science ®Google Scholar
• Tibaldi J, Pistorio A, Aldera E, et al. Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis. Rheumatology. 2020;59(11):3505–3514. doi:10.1093/rheumatology/keaa240
   PubMed Web of Science ®Google Scholar
• Weiss PF, Colbert RA, Xiao R, et al. Development and retrospective validation of the Juvenile Spondyloarthritis Disease Activity Index. Arthritis Care Res. 2014;66(12):1775–1782. doi:10.1002/acr.22411
   PubMed Web of Science ®Google Scholar
• Srinivasalu H, Treemarcki EB, Rumsey DG, Weiss PF, Colbert RA. Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol. 2022. doi:10.3899/jrheum.220509
   PubMed Web of Science ®Google Scholar
• Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum. 2005;52(7):2092–2102. doi:10.1002/art.21119
   PubMedGoogle Scholar
• Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202–1209. doi:10.1002/art.1780400703
   PubMed Web of Science ®Google Scholar
• van Rossum MAJ, Boers M, Zwinderman AH, et al. Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score. Arthritis Rheum. 2005;52(9):2865–2872. doi:10.1002/art.21247
   PubMedGoogle Scholar
• Bertamino M, Rossi F, Pistorio A, et al. Development and initial validation of a radiographic scoring system for the hip in juvenile idiopathic arthritis. J Rheumatol. 2010;37(2):432–439. doi:10.3899/jrheum.090691
   PubMed Web of Science ®Google Scholar
• Poznanski AK, Hernandez RJ, Guire KE, Bereza UL, Garn SM. Carpal length in children—a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology. 1978;129(3):661–668. doi:10.1148/129.3.661
   PubMed Web of Science ®Google Scholar
• Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs for Classification in Juvenile Spondyloarthritis. ACR Meeting Abstracts. Available from: https://acrabstracts.org/abstract/consensus-driven-definition-for-unequivocal-sacroiliitis-on-radiographs-for-classification-in-juvenile-spondyloarthritis/. Accessed January 11, 2023.
   Google Scholar
• Backström M, Tynjälä P, Aalto K, et al. Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis. RMD Open. 2019;5(1):e000888. doi:10.1136/rmdopen-2018-000888
   PubMed Web of Science ®Google Scholar
• Capela RC, Corrente JE, Magalhães CS. Comparison of the Disease Activity Score and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis. Rev Bras Reumatol Engl Ed. 2015;55(1):31–36. doi:10.1016/j.rbre.2014.08.009
   Google Scholar
• Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. 2011;63(7):929–936. doi:10.1002/acr.20497
   PubMed Web of Science ®Google Scholar
• Miller ML, Ruprecht J, Wang D, et al. Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records. Pediatr Rheumatol. 2011;9(1):9. doi:10.1186/1546-0096-9-9
   PubMedGoogle Scholar
• Backström M, Tarkiainen M, Gottlieb BS, et al. Paediatric rheumatologists do not score the physician’s global assessment of juvenile idiopathic arthritis disease activity in the same way. Rheumatology. 2023:kead151. doi:10.1093/rheumatology/kead151
   Web of Science ®Google Scholar
• Turk M, Pope JE. Physician global assessments for disease activity in rheumatoid arthritis are all over the map! RMD Open. 2018;4(1):e000578. doi:10.1136/rmdopen-2017-000578
   PubMed Web of Science ®Google Scholar
• Alongi A, Giancane G, Naddei R, et al. Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis. RMD Open. 2022;8(1):e002042. doi:10.1136/rmdopen-2021-002042
   PubMed Web of Science ®Google Scholar
• Knowlton N, Jiang K, Frank MB, et al. The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum. 2009;60(3):892–900. doi:10.1002/art.24298
   PubMed Web of Science ®Google Scholar
• Jiang K, Frank M, Chen Y, Osban J, Jarvis JN. Genomic characterization of remission in juvenile idiopathic arthritis. Arthritis Res Ther. 2013;15(4):R100. doi:10.1186/ar4280
   PubMed Web of Science ®Google Scholar
• Nordal E, Zak M, Berntson L, et al. Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting. Pediatr Rheumatol. 2011;9(S1):P155. doi:10.1186/1546-0096-9-S1-P155
   Google Scholar
• Consolaro A, Ruperto N, Bracciolini G, et al. Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score. Ann Rheum Dis. 2014;73(7):1380–1383. doi:10.1136/annrheumdis-2013-204186
   PubMed Web of Science ®Google Scholar
• Magni-Manzoni S, Ruperto N, Pistorio A, et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Care Res. 2008;59(8):1120–1127. doi:10.1002/art.23916
   Web of Science ®Google Scholar
• Sieper J, Van Der Heijde D, Landewe R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784–788. doi:10.1136/ard.2008.101501
   PubMed Web of Science ®Google Scholar
• Lurati A, Pontikaki I, Teruzzi B, et al. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents. Arthritis Rheum. 2006;54(5):1602–1607. doi:10.1002/art.21784
   PubMed Web of Science ®Google Scholar
• De Benedetti F, Brunner H, Ruperto N, et al. Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data; 2012:10. Available from: doi:10.1002/central/CN-01028625/full. Accessed September 30, 2023.
   Google Scholar
• Ruperto N, Brunner H, Quartier P, et al. Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2013;71. doi:10.1136/annrheumdis-2012-eular.1180
   Google Scholar
• Buckland J. Biologic therapy for systemic juvenile idiopathic arthritis—times they are a’changing! Nat Rev Rheumatol. 2013;9(2):63. doi:10.1038/nrrheum.2013.2
   PubMedGoogle Scholar
• Sharp JT, Young DY, Bluhm GB, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 1985;28(12):1326–1335. doi:10.1002/art.1780281203
   PubMed Web of Science ®Google Scholar
• Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol. 1995;22(10):1974–1975.
   PubMed Web of Science ®Google Scholar
• Rossi F, Di Dia F, Galipò O, et al. Use of the sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Care Res. 2006;55(5):717–723. doi:10.1002/art.22246
   Web of Science ®Google Scholar
• Poznanski AK. Radiological approaches to pediatric joint disease. J Rheumatol Suppl. 1992;33:78–93.
   PubMedGoogle Scholar
• What is PROMIS? PROMIS Health Organization. Available from: https://www.promishealth.org/57461-2/. Accessed May 8, 2023.
   Google Scholar
• Ader DN. Introduction: developing the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5):S1–S2. doi:10.1097/01.mlr.0000260537.45076.74
   PubMed Web of Science ®Google Scholar
• Consolaro A, Ruperto N, Pistorio A, et al. Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis. Arthritis Care Res. 2011;63(9):1262–1270. doi:10.1002/acr.20509
   Web of Science ®Google Scholar
• Filocamo G, Consolaro A, Schiappapietra B, et al. A new approach to clinical care of juvenile idiopathic arthritis: the juvenile arthritis multidimensional assessment report. J Rheumatol. 2011;38(5):938–953. doi:10.3899/jrheum.100930
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Brunner HI, Ringold S, et al. The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int. 2018;38(1):35–42. doi:10.1007/s00296-018-3984-6
   PubMedGoogle Scholar
• Varni JW, Seid M, Smith Knight T, Burwinkle T, Brown J, Szer IS. The PedsQLTM in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life InventoryTM generic core scales and rheumatology module. Arthritis Rheum. 2002;46(3):714–725. doi:10.1002/art.10095
   PubMed Web of Science ®Google Scholar
• Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761–1769. doi:10.1002/art.1780371209
   PubMed Web of Science ®Google Scholar
• Filocamo G, Sztajnbok F, Cespedes-cruz A, et al. Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis. Arthritis Care Res. 2007;57(6):913–920. doi:10.1002/art.22900
   Web of Science ®Google Scholar
• Wright V, Longo Kimber J, Law M, Goldsmith C, Crombie V, Dent P. The Juvenile Arthritis Functional Status Index (JASI): a Validation Study. J Rheumatol. 1996;23(6):1066–1079.
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Shear E, Hartner S, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The juvenile arthritis functional assessment scale. Arthritis Rheum. 1989;32(11):1390–1395. doi:10.1002/anr.1780321107
   PubMedGoogle Scholar
• Howe S, Levinson J, Shear E, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The juvenile arthritis functional assessment report for children and their parents. Arthritis Rheum. 1991;34(7):873–880. doi:10.1002/art.1780340713
   PubMed Web of Science ®Google Scholar
• Kvrgic Z, Asiedu GB, Crowson CS, Ridgeway JL, Davis JM. “Like No One Is Listening to Me”: a qualitative study of patient-provider discordance between global assessments of disease activity in rheumatoid arthritis. Arthritis Care Res. 2018;70(10):1439–1447. doi:10.1002/acr.23501
   Web of Science ®Google Scholar
• Mosor E, Studenic P, Alunno A, et al. Young people’s perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force. RMD Open. 2021;7(1):e001517. doi:10.1136/rmdopen-2020-001517
   PubMed Web of Science ®Google Scholar
• Ferreira RJO, de Wit M, Henriques M, et al. “It can’t be zero!” Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study. Rheumatology. 2020;59(5):1137–1147. doi:10.1093/rheumatology/kez467
   PubMed Web of Science ®Google Scholar
• Sztajnbok F, Coronel-Martinez DL, Diaz-Maldonado A, et al. Discordance between physician’s and parent’s global assessments in juvenile idiopathic arthritis. Rheumatology. 2007;46(1):141–145. doi:10.1093/rheumatology/kel201
   PubMed Web of Science ®Google Scholar
• Brandon TG, Becker BD, Bevans KB, Weiss PF. Patient-reported outcomes measurement information system tools for collecting patient-reported outcomes in children with juvenile arthritis. Arthritis Care Res. 2017;69(3):393–402. doi:10.1002/acr.22937
   Web of Science ®Google Scholar
• Craig J, Feldman BM, Spiegel L, Dover S. Comparing the measurement properties and preferability of patient-reported outcome measures in pediatric rheumatology: PROMIS vs CHAQ. J Rheumatol. 2021;48(7):1065–1072. doi:10.3899/jrheum.200943
   PubMed Web of Science ®Google Scholar
• Bovis F, Consolaro A, Pistorio A, et al; For the Paediatric Rheumatology International Trials Organisation (PRINTO). Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology. Rheumatol Int. 2018;38(S1):5–17. doi:10.1007/s00296-018-3944-1
   PubMedGoogle Scholar
• Ravelli A, Consolaro A, Horneff G, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018:annrheumdis-2018–213030. doi:10.1136/annrheumdis-2018-213030
   Google Scholar